Revvity | PKI - Le Bénéfice D'Exploitation

Prix De L'Action
87.37
Variation Quotidienne
0.89 1.03%
Mensuellement
-10.61%
Annuel
-22.47%
Q1 Prévisions
82.99




Le Bénéfice D'Exploitation Changement Date
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 382M 15.3M 2025-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Mesa Laboratories USD 5.78M 2.27M 2024-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Organigram Holdings CAD -28.05M 7.76M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Quidel USD -37.3M 667.5M 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Waters USD 270.52M 78.4M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09